Divi's Laboratories was in focus during Thursday's trading session as it has crossed the Rs 1 lakh crore mark in terms of market capitalisation.
The stock has had a strong run for and is up around 100 percent on a year-to-date basis and around 70 percent since March 2020.
In terms of valuations, it is currently at 40 times PE as compared to 23 times in March 2020 and around 26 times which is its five-year historical average.
One of the key reasons for this strong run-up is the kind of large capex that the company has approved to augment their capacities and take advantage of factors such as a probable shift of API manufacturing from China.
Watch the video for more